Open access · CC-BY
via OpenAlex
Age-Related Macular Degeneration: Epidemiology, Pathophysiology, Diagnosis, and Treatment
Hrishikesh Vyawahare, Pranaykumar Shinde
Cureus · 2022 · ▲ 126 citations
Abstract
The greatest global root of irremediable amaurosis in the venerable is age-related macular degeneration (AMD), a complex eye condition. Clinically, AMD is characterized as being in an early stage to late stage and initially affects the macula, which is the center of the retina (advanced AMD). Age-related cellular and metabolic imbalance are made worse by the creation of excessive amounts of free radical species, which causes mitochondrial malfunction. As a result, in AMD-affected eyes, the deprivation of melanocytes, confection, and eventually atrophy within the retinal tissue are caused by the continued proliferation of oxidative stress caused by systemic antioxidant capacity depletion. In the urbanized, industrialized world, age-related macular degeneration (AMD) is one of the major causes of central vision loss in the older age group. Although several causes and mechanisms for the dysfunction and degeneration of the retinal pigment epithelium (RPE) have previously been identified, the condition's symptoms are still not fully understood. Etiopathogenesis is still not entirely understood. As a result, the RPE fails, allowing an accumulation of aberrant misfolded proteins, due to the loss of anatomical control over oppression, altered homeostasis, dysfunctional lipid homeostasis, and failure of mitochondria. Due to the multitude of interconnected processes, numerous complicated therapy combinations will probably be the best option to deliver the best visual outcomes; these combinations will vary depending on the kind and degree of the condition being treated. Undoubtedly, this will lead to the development of customized preventative medications and, hopefully, the revelation of a potential cure. All the mechanisms involved in the etiology of AMD should be continuously probed to create covariates for other contemporaneous or future problems.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.7759/cureus.29583
- Canonical
- link ↗
- Fetched
- 2026-10-19 MST
Cite this
APA
Vyawahare, H., & Shinde, P. (2022). Age-Related Macular Degeneration: Epidemiology, Pathophysiology, Diagnosis, and Treatment. <em>Cureus</em>. https://doi.org/10.7759/cureus.29583
Vancouver
Vyawahare H, Shinde P. Age-Related Macular Degeneration: Epidemiology, Pathophysiology, Diagnosis, and Treatment. Cureus. 2022. doi:10.7759/cureus.29583.
BibTeX
@article{hrishikesh2022AgeRel,
title = {Age-Related Macular Degeneration: Epidemiology, Pathophysiology, Diagnosis, and Treatment},
author = {Hrishikesh Vyawahare and Pranaykumar Shinde},
journal = {Cureus},
year = {2022},
doi = {10.7759/cureus.29583},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Survey of Ophthalmology 1987
Citation only
Pathophysiology of age-related macular degeneration
BioMed Research International 2014
Open access · CC-BY
Oxidative Stress, Hypoxia, and Autophagy in the Neovascular Processes of Age-Related Macular Degeneration
PubMed 1999
Preprint · OA
Oxidative damage and age-related macular degeneration.
Neuron 2012
Open access · OA
Mechanisms of Age-Related Macular Degeneration
Cell and Tissue Research 2021
Open access · CC-BY
Subretinal fibrosis in neovascular age-related macular degeneration: current concepts, therapeutic avenues, and future perspectives
AIMS molecular science 2016
Open access · CC-BY